With proper medical guidance and access to quality medications, GLP-1 treatment can be both safe and effective for managing diabetes and achieving sustainable weight loss
This dose-response relationship across receptor activation suggests that the more pathways you stimulate, the higher the likelihood of neurological side effects including skin sensitivity
For patients I see in clinic, retatrutide may potentially be a highly impactful future tool to treat their obesity and transform their health trajectory." For the primary endpoint, participants taking retatrutide 9 mg and 12 mg lost an average of 64.4 lbs (25.9%) and 70.3 lbs (28.3%), respectively
Front Psychiatry 2022;13:813304
Its about freedom freedom to live fully, confidently, and yes, even enjoy your morning coffee
GLP-1 medications are not appropriate for everyone, and the safest plan depends on the patients medical history, current medications, goals, lab markers, and risk factors